Chambers and Partners has recognized Pomerantz LLP as one of the top plaintiffs’ securities litigation firms in the nation and in New York in 2020. Praising Pomerantz as “a prominent player on the plaintiffs' side,” Chambers credits the Firm for being a “highly regarded force [… ] known for taking on major corporate issuers.”
Read MoreOn April 22, 2020, Judge William F. Kuntz II in the U.S. District Court in the Eastern District of New York denied Blue Apron’s motion to dismiss our action in its entirety. In Re Blue Apron Holdings, Inc. Securities Litigation, alleges claims against Blue Apron, a subscription-based meal preparation service that went public in 2017.
Read MoreOn April 7, 2020, Pomerantz was appointed lead counsel in an action against Qudian Inc., concerning materially false and misleading statements regarding its response to regulatory developments in China that threatened to negatively impact Qudian’s full year 2019 financial results, when in reality Qudian’s business was unprepared to mitigate the risks associated with these changes.
Read MoreOn April 7, 2020, Pomerantz LLP was appointed Lead Counsel in a class action lawsuit against Domo, Inc., brought on by concerns that Domo and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
Read MoreOn April 6, 2020, Pomerantz succeeded in both defeating the Defendants’ motion to dismiss the third amended complaint against Mylan Pharmaceuticals and in getting the class certified by Judge Oetken in the Southern District of New York.
Read MoreOn March 23, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Forescout Technologies, Inc.
Read MoreOn February 12, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Twitter, Inc, regarding its misrepresentation of “fixes” to user choice settings, which adversely affected its ability to deliver monetized advertisements.
Read MoreOn February 11, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Canopy Growth Corporation, alleging that the Company issued false and/or misleading statements …
Read MoreOn February 3, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against PG&E Corporation, alleging that PG&E’s new, “enhanced” wildfire prevention and safety protocols were misrepresented as adequate …
Read MoreOn January 10, 2020, Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit against Zynerba Pharmaceuticals, Inc., regarding allegations that Zynerba failed to disclose details discovered in trials of its transdermal CBD gel product, Zygel.
Read MoreOn January 7, 2020, Pomerantz LLP was appointed Lead Counsel in a class action lawsuit against Match Group, Inc., regarding allegations that the Company failed to disclose adverse facts about its practice of bating customers of its dating products with fake love interest ads …
Read MoreOn January 2, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Eldorado Resorts, Inc., alleging that several of the Company’s officers knowingly disregarded Eldorado’s Code of Ethics and Business Conduct.
Read MoreOn December 27, 2019, Pomerantz LLP announced that it has filed a securities fraud lawsuit on behalf of several dozen institutional investors in conjunction with the ISAF-Danske Coalition (International Securities Associations and Foundations Management Company for Damaged Danske Investors).
Read MoreOn December 30, 2019, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Altria Group and certain of its senior officers concerning the nature of its investment in JUUL Labs, Inc in December, 2018.
Read MoreOn December 26, 2019, Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit against International Flavors & Fragrances, Inc, in the United States District Court for the Southern District of New York.
Read MorePomerantz LLP was appointed Lead Counsel in a securities litigation class action against Sarepta Therapeutics, Inc. and certain of its senior officers for violation of the federal securities laws.
Read MoreOn November 20, 2019, Pomerantz LLP was appointed Lead Counsel in Padilla v. Community Health Systems, Inc., a securities class action litigation in the Middle District of Tennessee.
Read MorePomerantz LLP was appointed lead counsel in a securities litigation class action lawsuit against Aclaris Therapeutics, Inc.
Read MorePomerantz Managing Partner featured on Lawdragon. Read here!
Read MorePomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Intelligent Systems Corporation.
Read More